NCT06997887 is a NA clinical trial of CH2 vaginal gel in Gynecologic Malignancy, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT06997887?

NCT06997887 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT06997887?

Interventions in NCT06997887: CH2 vaginal gel, vaginal rehabilitation exercises.

What condition does NCT06997887 study?

NCT06997887 studies Gynecologic Malignancy.

Is NCT06997887 still recruiting?

NCT06997887 is currently recruiting now. Last updated 27 June 2025.

Last reviewed 2025-06-27 · How we verify

NCT06997887

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy

Recruiting now NA Last updated 27 June 2025

What this trial tests

NA trial testing CH2 vaginal gel in Gynecologic Malignancy in 60 participants. Currently enrolling.

Timeline

9 May 2025

Primary endpoint
9 May 2028

9 May 2030

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	60
Start date	9 May 2025
Primary completion	9 May 2028
Estimated completion	9 May 2030
Sites	1 location across Taiwan

Drugs / interventions tested

CH2 vaginal gel
vaginal rehabilitation exercises

Conditions studied

Gynecologic Malignancy — all drugs for Gynecologic Malignancy →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 70, female only, with Gynecologic Malignancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06997887 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 27 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06997887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing